CLIA Kit for Phospholipase A2, Lipoprotein Associated (LpPLA2)

Format

48T, 96T, 96T×5, 96T×10, 96T×100
Detection range

13.7-10,000pg/mL
Application

Chemiluminescent immunoassay for Antigen Detection.
Organism species

Homo sapiens (Human)
Sensitivity

The minimum detectable dose of this kit is typically less than 4.8pg/mL
Sample type

Serum, plasma and other biological fluids
Manual Links
Assay length

2h, 40min
Method

Double-antibody Sandwich
Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Alternative Names

PLA2G7; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2
Item Name

Phospholipase A2, Lipoprotein Associated
Research Area

Enzyme & Kinase;Metabolic pathway;Infection immunity;

Gene target

CLIA Kit for Phospholipase Lipoprotein Associated LpPLA2
Short name

CLIA Kit for Phospholipase A2, Lipoprotein Associated (LpPLA2)
Alternative name

CLIA reagent to measure Phospholipase A2, Lipoprotein Associated (LpPLA2)
Alternative technique

kits
Alternative to gene target

v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, C-Kit and CD117 and PBT and SCFR, KIT and IDBG-18980 and ENSG00000157404 and 3815, transferase activity, Extracellular, Kit and IDBG-172083 and ENSMUSG00000005672 and 16590, KIT and IDBG-642326 and ENSBTAG00000002699 and 280832